Nasdaq Stock: Inflation Data Looms as Tech Rally Hangs in Balance
The Nasdaq opened the week with mixed signals, slipping 0.3% on Monday despite futures briefly flirting with record highs. Investors...
Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory.
With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.
The Nasdaq opened the week with mixed signals, slipping 0.3% on Monday despite futures briefly flirting with record highs. Investors...
Apple announced a quarterly dividend of $0.26 per share (approximately €0.22), reinforcing confidence in its financial stability despite ongoing challenges....
Rheinmetall shares plummeted over 4% on Monday, emerging as one of the German market's worst performers amid broader gains. The...
Northern Data has announced plans to sell its Bitcoin mining division, Peak Mining, to Elektron Energy for up to $235...
Coinbase's Q2 results shocked investors, with revenue of $1.5 billion falling short of the projected $1.59 billion. Trading volume plummeted...
The Trade Desk's stock plummeted 32% on Friday after a major analyst downgrade, slashing its price target from $75 to...
Despite posting a record Q2 profit of €2.1 billion—a 30% surge driven by unusually low natural catastrophe costs (€20 million...
Insulet, a leading medical technology company, has impressed Wall Street with stellar quarterly results, prompting multiple analysts to raise price...
Berlin-based radiation and medical technology firm Eckert & Ziegler reported solid first-half 2025 results, with revenue rising 2% to €148.8...
Gilead Sciences surprised investors with stronger-than-expected Q2 results, driven by a surge in its HIV portfolio. The biotech giant reported...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com